DF/HCC Cancer Risk, Prevention, and Early Detection (CaRPED) Brief Updates Symposium

On an annual basis, the Dana Farber/Harvard Cancer Center Population Science Programs invite members to give an overview of the exciting scientific innovations and progress being made. The goal of this “Brief Updates” series is to share scientific advancements, facilitate active communication, build new collaborations, and show synergy across the Population Sciences programs.

Thursday, May 19, 2022
2:00-5:00 PM ET

What’s New in Cancer Risk, Prevention, and Early Detection (CaRPED) at DF/HCC
Virtual Symposium

Agenda:

		Presenter
2:00-2:05	Welcome and Introductions	Sapna Syngal, MD, MPH Leader, CaRPED Program, DF/HCC
2:05-2:35	Keynote Address: Early Cancer Detection Strategies Using Ultrasensitive Protein Biomarkers	David R. Walt, Ph.D Professor of Pathology, Brigham and Women’s Hospital Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School Core Faculty, Wyss Institute for Bioinspired Engineering, Harvard University Howard Hughes Medical Institute Professor
2:35-2:45	Q&A
	CaRPED and Community Outreach
	Moderator: Lecia Sequist, MD, MPH Leader, CaRPED Program, DF/HCC
2:45-3:00	Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening (CARES) – A Stand Up To Cancer Dream Team	Jennifer Haas, MD, MSPH Director, Center for Primary Care Research, Massachusetts General Hospital Professor of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health Professor of Medicine, Harvard Medical School
3:00-3:15	The Implementation Science Center for Cancer Control Equity (P50) – Making What We Know What We Do	Karen Emmons, PhD Faculty Director, Community Engagement Program, Harvard Catalyst Professor of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health
3:15-3:25	Q & A
	CaRPED and Novel Diagnostics
	Moderator: Gary Tearney, MD, PhD Leader, CaRPED Program, DF/HCC
3:25-3:40	The MIDE study: A novel microRNA assay for early detection of ovarian cancer	Dipanjan Chowdhury, PhD Chief, Division of Radiation and Genomic Stability, Dana-Farber Cancer Institute Svanberg Family Chair, Dana-Farber Cancer Institute Professor of Radiation Oncology, Harvard Medical School
3:40-3:55	Improving outcomes for patients with genitourinary malignancies through cfDNA analysis	Jacob Berchuck, MD Medical Oncologist, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute Instructor of Medicine, Harvard Medical School
3:55-4:05	Selected Abstract - Detection of circulating tumor human papillomavirus DNA years before diagnosis of HPV-positive head and neck cancer	Saskia Naegele Research Scholar, Faden Lab, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear
4:05-4:15	Q & A
4:15-4:45	Discussion with CaRPED Leaders about Future Grants and Collaborations Moderators: Giovanni Parmigiani, PhD and Lorelei Mucci, MPH, ScD DF/HCC Population Science Programs Leaders	Lecia Sequist, MD, MPH, Sapna Syngal, MD, MPH, and Gary Tearney, MD, PhD Leaders, CaRPED Program, DF/HCC

Click on the Zoom icon below to register or CLICK HERE
If you are having trouble logging into the meeting, please feel to contact us by clicking on the contact us tab.